Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC

Clinical trial NCT05244213 · UNKNOWN

Trial details

NCT number: NCT05244213
Sponsor: Guangdong Provincial People's Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer EGFR Activating Mutation

Start date: 2022-06-04
Primary completion: 2024-06-05
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.